Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin LymphomaMartin Hutchings, Michael Dickinson, Emmanuel Bachy et al.|Blood|2020Cited by 56